Full-Time

Patient Services Liaison

Care Access

Care Access

501-1,000 employees

Global health education, access, and research

Compensation Overview

$17 - $26/hr

No H1B Sponsorship

Brandon, FL, USA

In Person

On-site position with regional commute requirements; occasional planned regional travel is required, with minimal overnight travel.

Bachelor's

Category
Medical, Clinical & Veterinary (1)
Required Skills
Word/Pages/Docs
Excel/Numbers/Sheets
Microsoft Outlook

Get referred to Care Access

See people who can refer or advise you

Requirements
  • Ability to communicate and work effectively with a diverse team of professionals.
  • Ability to prioritize, delegate, direct, support, assign, and evaluate others' work and follow through on assignments.
  • Strong verbal and written communication skills demonstrated through positive interactions with coworkers, management, patients, and vendors.
  • Ability to work effectively and collaboratively with other team members to accomplish mutual goals.
  • Strong computer skills, including demonstrated ability to use a clinical trials database, Microsoft Word, and Microsoft Excel.
  • Ability to balance tasks with competing priorities.
  • Critical-thinking and problem-solving ability.
  • Curiosity and willingness to learn and innovate, take thoughtful risks, and complete work effectively.
  • Friendly, outgoing personality with the ability to maintain a positive attitude under pressure.
  • High level of self-motivation, energy, and urgency.
  • Ability to work independently in a fast-paced environment with minimal supervision.
  • Ability to adapt to changes in responsibilities and workloads.
  • Patient-service mentality.
  • Bachelor's Degree or equivalent experience.
  • At least 2 years of experience in patient services, clinical coordination, or a healthcare-related role.
  • Understanding of GDPR (RODO) regulations and patient privacy standards.
  • Familiarity with Microsoft tools, including Excel, Word, PowerPoint, and Outlook.
  • Communicative knowledge of English.
Responsibilities
  • Serve as the primary point of contact for patients, providing clear and timely communication regarding study procedures, visit schedules, and expectations.
  • Coordinate, schedule, confirm, and reschedule patient visits in alignment with protocol requirements and site capacity.
  • Maintain accurate site calendars and patient visit diaries, ensuring alignment across investigators, coordinators, and site staff.
  • Support patient use of study-related applications, diaries, and required documentation when delegated on the study.
  • Support the Future of Medicine program by supporting healthcare screenings and guiding patients through the care experience.
  • Perform day-to-day administrative tasks to support smooth site operations, including documentation preparation, filing, and record maintenance.
  • Manage site diaries, calendars, and appointment systems to ensure visibility and accuracy of patient visits and site activities.
  • Prepare visit-specific materials, documents, and devices in accordance with visit schedules and study protocols.
  • Ensure accurate registration of appointments and timely updates in operational systems.
  • Support logistics coordination related to patient visits.
  • Work closely with investigators and site staff to ensure seamless patient flow and visit execution.
  • Build and maintain relationships with patients to support retention and a positive site experience.
  • Cooperate with external service providers, including couriers, cleaning services, and equipment suppliers, to support site readiness.
  • Address patient inquiries and concerns with professionalism, empathy, and discretion.
  • Resolve routine patient issues and escalate complex cases to appropriate clinical or operational leadership.
Desired Qualifications
  • Experience in clinical trials or a research setting.

Care Access coordinates global efforts to improve health by educating people about health, helping them access needed resources, and enabling participation in medical research to develop new medicines and cures. Its approach involves a global network and services that educate individuals, connect them with health resources, and recruit participants for clinical studies, thereby supporting the development of new treatments. Unlike companies that focus on a single market or product, Care Access operates worldwide and focuses on easing access to information, services, and research opportunities for diverse populations. The goal is to make health information and access more available and participation in health studies easier, with the aim of making the future of health better for everyone.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Boston, Massachusetts

Founded

2016

Get referred to Care Access

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Walmart opened first Care Access sites in Texas and Georgia on 2026-04-29.
  • Care Access reported 852 employees and 163 active 2026 job postings.
  • The company added Warsaw in 2024 and CEMEC in Brazil in 2025.

What critics are saying

  • Walmart locations in Houston, Tyler, and Dalton hinge on flawless spring 2026 execution.
  • Pfizer and Valneva blamed Care Access in 2023; sponsor trust remains fragile.
  • If a major sponsor exits after a compliance failure, the decentralized model collapses.

What makes Care Access unique

  • Care Access pairs community screenings with Phase 2-4 trials inside Walmart stores, 2026.
  • Its decentralized model uses mobile clinics, Sites On Demand, and local partnerships globally.
  • Brazil, Poland, and U.S. sites create a geographically distributed recruitment engine.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Growth & Insights and Company News

Headcount

6 month growth

-4%

1 year growth

-4%

2 year growth

-4%
8th & Walton
Apr 29th, 2026
Walmart brings clinical trials into the community - walmart.com.

Walmart brings clinical trials into the community - walmart.com. Walmart is bringing clinical research into everyday community spaces through the Walmart Healthcare Research Institute and a new Clinical Trial Center collaboration with Care Access. Key takeaways. * Research closer to home: The Clinical Trial Center by Walmart and Care Access is opening initial sites in Houston and Tyler, Texas, and Dalton, Georgia, placing trial locations inside familiar store environments. * Focus on underserved communities: Walmart Healthcare Research Institute was created to expand access to clinical trials and improve care for communities historically underrepresented in research. * New model for medical innovation: Care Access will run screenings and trials, while Walmart supports outreach, with leaders describing the effort as a new way to deliver clinical research.

SmartBrief
Jan 22nd, 2026
Walmart, Care Access to partner on clinical research

Walmart, Care Access to partner on clinical research. Walmart will partner with Care Access to launch a clinical research initiative this spring that will bring clinical trial opportunities to markets, including rural areas that often lack access to cutting-edge medical research. The retailer will open research sites at select stores and former Walmart Health clinic locations. By using familiar community spaces, Walmart hopes to make participation in clinical research more accessible and convenient for local residents. Designed specifically for retail professionals, NRF SmartBrief is a free, daily email newsletter. It provides the latest need-to-know news and industry information that maximizes your time, giving you an edge over your competition.

First Free Church Chicago
Dec 1st, 2024
Care Access Senior Fair | December 6 + 7

On December 6th and 7th Firstfree is partnering with Care Access, an organization with a mission to connect the community with equitable health research.

Business Wire
Mar 18th, 2024
Care Access Opens New Clinical Research Site In Warsaw, Poland

BOSTON--(BUSINESS WIRE)--Care Access, a global clinical research site company helping to accelerate the future of medicine, has opened its newest research site in Warsaw, Poland. The company’s expansion in Poland reinforces its commitment to improving access to clinical research globally through its innovative model of bringing clinical trials wherever they are needed. In recent years, Care Access has been active in clinical research across Europe, and now, by establishing a new facility in Warsaw, Care Access is further expanding its European services aimed to implement its industry-leading research capabilities, such as its Community Screening Program, Sites On Demand, and Mobile Research Site Infrastructure. These capabilities have shown to accelerate research study enrollment by adapting to the unique makeup of each community and providing more convenient ways to participate in clinical trials. “Poland plays an important role in bringing the future of medicine to reality,” said Rupi Bancil, Senior Vice President of Global Study Operations Expansion for Care Access. “The Warsaw site will improve access to advanced health screenings and research opportunities to communities throughout Poland.”

Business Wire
Mar 4th, 2024
New Study Addressing Global Concern For Breast Cancer Treatment Now Available In Clifton, N.J.

BOSTON--(BUSINESS WIRE)--A cancer research study focusing on hormone receptor-positive HER2-negative (HR+/HER2-) metastatic breast cancer (MBC) is now available to patients in the Clifton, N.J., area. The SERENA-6 trial, sponsored by AstraZeneca, is a global study that aims to address a critical issue faced by many patients: their treatments become less effective over time. In advanced breast cancer, patients receive a treatment that combines an estrogen-reducing drug with a drug that slows cancer cell growth. While this combination works well, over time, it may stop working because of mutations in the ESR1 gene. This study will evaluate if an experimental trial drug, combined with a cancer-slowing drug, might work better than conventional estrogen-reducing drugs for patients with ESR1 mutations